Chimeric Therapeutics Ltd
ASX:CHM
Chimeric Therapeutics Ltd
ASX:CHM
Price:
0.002
AUD
Market Cap:
AU$8.8m
Income Statement
Earnings Waterfall
Chimeric Therapeutics Ltd
Chimeric Therapeutics Ltd
Income Statement
Chimeric Therapeutics Ltd
Chimeric Therapeutics Ltd
Currency: AUD
| Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
4
N/A
|
|
| Gross Profit | ||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
3
N/A
|
|
| Operating Income | ||||||||
| Operating Expenses |
(15)
|
(17)
|
(26)
|
(11)
|
(11)
|
(18)
|
(13)
|
|
| Selling, General & Administrative |
(11)
|
(13)
|
(15)
|
(12)
|
(9)
|
(9)
|
(7)
|
|
| Research & Development |
(5)
|
(9)
|
(13)
|
(12)
|
(10)
|
(11)
|
(13)
|
|
| Depreciation & Amortization |
(1)
|
0
|
(1)
|
0
|
(1)
|
0
|
(1)
|
|
| Other Operating Expenses |
2
|
5
|
4
|
13
|
9
|
2
|
9
|
|
| Operating Income |
(15)
N/A
|
(17)
-14%
|
(26)
-49%
|
(11)
+58%
|
(11)
-5%
|
(18)
-56%
|
(10)
+43%
|
|
| Pre-Tax Income | ||||||||
| Interest Income Expense |
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
0
|
(0)
|
|
| Non-Reccuring Items |
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
|
| Pre-Tax Income |
(16)
N/A
|
(18)
-12%
|
(26)
-46%
|
(12)
+54%
|
(13)
-6%
|
(18)
-41%
|
(10)
+41%
|
|
| Net Income | ||||||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(16)
|
(18)
|
(26)
|
(12)
|
(13)
|
(18)
|
(10)
|
|
| Net Income (Common) |
(16)
N/A
|
(18)
-13%
|
(26)
-44%
|
(12)
+55%
|
(13)
-7%
|
(18)
-42%
|
(10)
+42%
|
|
| EPS (Diluted) |
-0.04
N/A
|
-0.04
N/A
|
-0.06
-50%
|
-0.03
+50%
|
-0.02
+33%
|
-0.02
N/A
|
-0.01
+50%
|
|
Switch to:
Switch to:
See Also
Discover More
